Reply to ‘Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?’
Guardado en:
Autores principales: | Assad Shiti, Idit Goldfracht, Naim Shaheen, Stephanie Protze, Lior Gepstein |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/419b4694c7dd4aeca6ebb99f29e4bade |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Generating ring-shaped engineered heart tissues from ventricular and atrial human pluripotent stem cell-derived cardiomyocytes
por: Idit Goldfracht, et al.
Publicado: (2020) -
Are atrial human pluripotent stem cell-derived cardiomyocytes ready to identify drugs that beat atrial fibrillation?
por: Torsten Christ, et al.
Publicado: (2021) -
Modeling Atrial Fibrillation using Human Embryonic Stem Cell-Derived Atrial Tissue
por: Zachary Laksman, et al.
Publicado: (2017) -
Left Ventricular Systolic Dysfunction Due to Atrial Fibrillation: Clinical and Echocardiographic Predictors
por: Erez Marcusohn, et al.
Publicado: (2021) -
Atrial Myopathy Underlying Atrial Fibrillation
por: Harold Rivner, et al.
Publicado: (2020)